Fundraising Fox

Veriskin

San Diego, US · Founded 2016 · Delaware corporation · 1 known investors

Founders & leadership

MC
Mirianas ChachisvilisinExecutive
KH
Kevin HerzbergNamed on SEC filing
JF
John FitzgibbonNamed on SEC filing
ET
Eugene TuNamed on SEC filing
CE
Carl EdmanNamed on SEC filing

Investors · 1

Reported raises · per SEC filings

Form D private placements

$682.3K disclosed across 1 round · 2020

$682.3KraisedNov 2020 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin HerzbergDirector
  • John FitzgibbonDirector
  • Eugene TuDirector
  • Mirianas ChachisvilisExecutive Officer, Director
  • Carl EdmanDirector
Offering amount
$1.5M
Amount sold
$682.3K
First sale
Oct 2020
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 3 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2022$2.3M
National Institutes of Health (NIH)National Institutes of HealthPhase II2020$2M
National Institutes of Health (NIH)National Institutes of HealthPhase II2016$1.9M

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

Who are Veriskin's investors?
Veriskin's investors include Pasadena Angels.
How much funding has Veriskin raised?
Veriskin has disclosed $682.3K raised across 1 round.
Where is Veriskin headquartered?
Veriskin is headquartered in San Diego, US.